InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| REGN-CoV-derived Anti-SARS-CoV-2 RBD monoclonal antibodies | Homologous or heterogenous vaccination boosters enhance neutralizing activiti... | 2022 | MedComm. | Zhou Z. et al. | DOI: 10.1002/mco2.143 |
| LY-CoV2-derived Anti-SARS-CoV-2 RBD monoclonal antibodies | Homologous or heterogenous vaccination boosters enhance neutralizing activiti... | 2022 | MedComm. | Zhou Z. et al. | DOI: 10.1002/mco2.143 |
| Caspase-8 inhibitor - Z-IETD-FMK | Z-DNA binding protein 1 mediates necroptotic and apoptotic cell death pathway... | 2022 | J Neuroinflammation | Jeffries A.M. et al. | DOI: 10.1186/s12974-022-02469-z |
| Pan-Caspase inhibitor - Z-VAD-FMK | Z-DNA binding protein 1 mediates necroptotic and apoptotic cell death pathway... | 2022 | J Neuroinflammation | Jeffries A.M. et al. | DOI: 10.1186/s12974-022-02469-z |
| QUANTI-Luc™: Luciferase Detection Reagent | Establishment of a luciferase-based method for measuring cancer cell adhesion... | 2022 | Anal Biochem | Jessen S.B. et al. | DOI: 10.1016/j.ab.2022.114723 |
| Lucia® luciferase Gene | Establishment of a luciferase-based method for measuring cancer cell adhesion... | 2022 | Anal Biochem | Jessen S.B. et al. | DOI: 10.1016/j.ab.2022.114723 |
| Adju-Phos® adjuvant | Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein... | 2022 | Sci Rep. | Stark F.C. et al. | DOI: 10.1038/s41598-022-13819-5 |
| HEK-Blue™ Detection | Zinc Metalloprotease ProA from Legionella pneumophila Inhibits the Pro-Inflam... | 2022 | Biomolecules | Scheithauer L. et al. | DOI: 10.3390/biom12050624 |
| Human TLR5 Reporter HEK293 Cells (NF-κB) | Zinc Metalloprotease ProA from Legionella pneumophila Inhibits the Pro-Inflam... | 2022 | Biomolecules | Scheithauer L. et al. | DOI: 10.3390/biom12050624 |
| Bafilomycin A1 | Multi-omics approach reveals posttranscriptionally regulated genes are essent... | 2022 | iScience | Iwasaki M. et al. | DOI: 10.1016/j.isci.2022.104289 |
| HKCA | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| Ionomycin | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| Zymosan | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| HKSA | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| PMA - Phorbol myristate acetate | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| Curdlan | Invasive Rhinosinusitis Caused by Alternaria infectoria in a Patient with Aut... | 2022 | J Fungi (Basel) | Paccoud O. et al. | DOI: 10.3390/jof8050446 |
| NLRP3 KO & KD THP-1 Cells | Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to A... | 2022 | Pharmaceuticals (Basel) | Tengesdal I.W. et al. | DOI: 10.3390/ph15050574 |
| THP1-Null Cells | Activation of Host-NLRP3 Inflammasome in Myeloid Cells Dictates Response to A... | 2022 | Pharmaceuticals (Basel) | Tengesdal I.W. et al. | DOI: 10.3390/ph15050574 |
| TLR5 | Intranasal Immunization with Zika Virus Envelope Domain III-Flagellin Fusion ... | 2022 | Pharmaceutics | Chen C.H. et al. | DOI: 10.3390/pharmaceutics14051014 |
| Recombinant anti-PD-L1 antibodies (D265A) - InvivoFit™ | Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to... | 2022 | Nat Cancer | Falcomatà C. et al. | DOI: 10.1038/s43018-021-00326-1 |